Fig. 3From: Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine gliomaRNAseq analysis of treated samples in DIPG cells. t-SNE plot of treatment samples with vehicle control (0.1% DMSO), 1 µM of MMF, 2 nM of triptolide, and 30 µM of triamterene in SF8628 (A, left) and SU-DIPG-IV (B, left) cells. MMF reversed the DIPG disease gene expression in SF8628 (A, right) and SU-DIPG-IV (B, right) cellsBack to article page